Euroopa Liit - malta - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - sklerosi multipla - drogi oħra tas-sistema nervuża - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Euroopa Liit - malta - EMA (European Medicines Agency)

mylan ireland limited - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Euroopa Liit - malta - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Euroopa Liit - malta - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Euroopa Liit - malta - EMA (European Medicines Agency)

dechra regulatory b.v. - meloxicam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation ta ' l-infjammazzjoni u l-uġigħ fil kronika disturbi muskolu-skeletrali. dogsalleviation mill-infjammazzjoni u uġigħ akut kif ukoll kroniku disturbi muskolu-skeletrali.

Euroopa Liit - malta - EMA (European Medicines Agency)

ge healthcare b.v. - ioflupane (123l) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - radjofarmaċewtiċi dijanjostiċi - dan il-prodott mediċinali huwa għal użu dijanjostiku biss. datscan huwa indikat għall-osservazzjoni telf tal-funzjonali tan-newroni dopaminerġiċi terminali fl-istriatum:f'pazjenti adulti b'klinikament inċerti u sindromi ta'parkinson, per eżempju dawk b'sintomi bikrija, biex jgħin jagħraf bejn tregħid essenzjali u sindromi ta'parkinson relatati mal-marda idjopatika ta ' parkinson, atrofija multipla tas-sistema u progressive supranuclear palsy. datscan huwa f'pożizzjoni li jiddistingwi bejn il-marda ta'parkinson, atrofija multipla tas-sistema u progressive supranuclear palsy. f'pazjenti adulti, li jgħin biex jiddistingwi-probabbiltà ta ' dimenzja b'lewy bodies mill-marda ta'alzheimer. datscan ma jistgħux jiddiskriminaw bejn dimenzja mal-korpi lewy u l-marda ta ' parkinson id-dimenzja.

Euroopa Liit - malta - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - marda ta 'parkinson - mediċini kontra l-parkinson - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Euroopa Liit - malta - EMA (European Medicines Agency)

takeda gmbh - pantoprazole - reflux gastroesofagi - inibituri tal-proton pump - trattament fuq medda qasira ta 'żmien ta' sintomi ta 'rifluss (e. ħruq ta 'stonku, riġenerazzjoni tal-aċidu) fl-adulti.

Euroopa Liit - malta - EMA (European Medicines Agency)

glaxosmithkline dungarvan limited - esomeprazole - reflux gastroesofagi - inibituri tal-proton pump - il-kontroll tan-nexju huwa indikat għat-trattament għal żmien qasir tas-sintomi tar-rifluss (e. heartburn u aċidu regurgitation) fl-adulti.

Euroopa Liit - malta - EMA (European Medicines Agency)

takeda gmbh - pantoprazole - reflux gastroesofagi - inibituri tal-proton pump - trattament fuq medda qasira ta 'żmien ta' sintomi ta 'rifluss (e. ħruq ta 'stonku, riġenerazzjoni tal-aċidu) fl-adulti.